US Stock MarketDetailed Quotes

VIRX Viracta Therapeutics

Watchlist
  • 0.143
  • -0.005-3.31%
Close Nov 29 13:00 ET
  • 0.168
  • +0.025+17.48%
Post 17:01 ET
5.68MMarket Cap-130P/E (TTM)

Viracta Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
32.67%-7.09M
-22.99%-9.83M
30.78%-7.85M
-12.51%-39.89M
-26.88%-10.03M
-47.20%-10.54M
11.56%-7.99M
0.20%-11.34M
-88.09%-35.46M
-9.60%-7.9M
Net income from continuing operations
16.25%-10.55M
21.26%-9.83M
25.13%-9.14M
-3.78%-51.06M
-33.30%-13.77M
28.99%-12.6M
-17.97%-12.48M
-15.77%-12.21M
57.13%-49.2M
9.79%-10.33M
Depreciation and amortization
-14.06%110K
-19.33%96K
-9.84%110K
134.29%492K
115.79%123K
184.44%128K
120.37%119K
125.93%122K
17.98%210K
-3.39%57K
Change In working capital
227.54%2.22M
-142.44%-1.25M
62.23%-318K
735.36%5.08M
258.63%2.31M
-77.88%679K
735.50%2.94M
68.14%-842K
-63.81%608K
-72.86%643K
-Change in prepaid assets
98.99%396K
-77.06%320K
69.92%-114K
245.28%1.43M
337.36%216K
-67.22%199K
3,132.61%1.4M
73.95%-379K
5.74%-985K
-128.98%-91K
-Change in payables and accrued expense
433.53%1.83M
-211.88%-1.56M
-134.88%-1.42M
198.74%3.09M
168.73%1.95M
-84.36%343K
350.81%1.4M
54.48%-605K
-43.52%1.03M
-62.07%726K
-Change in other current assets
--0
--0
759.15%1.22M
-0.18%566K
0.00%142K
-0.70%141K
0.00%141K
0.00%142K
-35.86%567K
0.71%142K
-Change in other current liabilities
50.00%-2K
-200.00%-3K
---3K
42.86%-4K
97.76%-3K
-103.13%-4K
--3K
--0
-158.33%-7K
---134K
Cash from discontinued investing activities
Operating cash flow
32.67%-7.09M
-22.99%-9.83M
30.78%-7.85M
-12.51%-39.89M
-26.88%-10.03M
-47.20%-10.54M
11.56%-7.99M
0.20%-11.34M
-88.09%-35.46M
-9.60%-7.9M
Investing cash flow
Cash flow from continuing investing activities
-10.31%8.16M
194.05%11.7M
293.09%14.19M
127.84%15M
4,666.50%9.27M
117.48%9.1M
347.82%3.98M
-7.35M
-517.86%-53.87M
-968.42%-203K
Net PPE purchase and sale
--0
----
----
-206.67%-138K
--0
5,200.00%51K
----
----
82.14%-45K
--0
Net investment purchase and sale
-9.80%8.16M
180.71%11.7M
293.09%14.19M
128.12%15.14M
4,666.50%9.27M
117.38%9.05M
366.90%4.17M
---7.35M
---53.82M
---203K
Cash from discontinued investing activities
Investing cash flow
-10.31%8.16M
194.05%11.7M
293.09%14.19M
127.84%15M
4,666.50%9.27M
117.48%9.1M
347.82%3.98M
---7.35M
-517.86%-53.87M
-968.42%-203K
Financing cash flow
Cash flow from continuing financing activities
-1.92M
-78.92%43K
-41,337.50%-6.6M
-98.06%438K
-98.98%218K
0
750.00%204K
100.00%16K
-63.89%22.54M
10,857.29%21.41M
Net issuance payments of debt
---1.92M
---1K
---6.68M
--0
--0
--0
--0
--0
8,641.03%19.99M
----
Net common stock issuance
--0
--0
--80K
-87.17%299K
-86.74%172K
--0
--127K
--0
-96.26%2.33M
--1.3M
Proceeds from stock option exercised by employees
--0
-42.86%44K
--0
-38.22%139K
-62.90%46K
--0
220.83%77K
128.57%16K
-33.63%225K
254.29%124K
Cash from discontinued financing activities
Financing cash flow
---1.92M
-78.92%43K
-41,337.50%-6.6M
-98.06%438K
-98.98%218K
--0
750.00%204K
100.00%16K
-63.89%22.54M
10,857.29%21.41M
Net cash flow
Beginning cash position
-2.18%13.98M
-33.36%12.06M
-66.51%12.32M
-64.49%36.77M
-45.23%12.86M
-82.48%14.29M
-80.37%18.1M
-64.49%36.77M
119.91%103.55M
-78.85%23.47M
Current changes in cash
40.57%-854K
150.42%1.92M
98.63%-255K
63.38%-24.46M
-104.05%-539K
97.53%-1.44M
64.15%-3.81M
-64.46%-18.67M
-218.27%-66.78M
279.04%13.3M
End cash Position
2.11%13.13M
-2.18%13.98M
-33.36%12.06M
-66.51%12.32M
-66.51%12.32M
-45.23%12.86M
-82.48%14.29M
-80.37%18.1M
-64.49%36.77M
-64.49%36.77M
Free cash flow
32.34%-7.09M
-20.15%-9.83M
30.78%-7.85M
-12.75%-40.03M
-26.88%-10.03M
-46.47%-10.48M
9.90%-8.18M
0.20%-11.34M
-53.67%-35.5M
-9.31%-7.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 32.67%-7.09M-22.99%-9.83M30.78%-7.85M-12.51%-39.89M-26.88%-10.03M-47.20%-10.54M11.56%-7.99M0.20%-11.34M-88.09%-35.46M-9.60%-7.9M
Net income from continuing operations 16.25%-10.55M21.26%-9.83M25.13%-9.14M-3.78%-51.06M-33.30%-13.77M28.99%-12.6M-17.97%-12.48M-15.77%-12.21M57.13%-49.2M9.79%-10.33M
Depreciation and amortization -14.06%110K-19.33%96K-9.84%110K134.29%492K115.79%123K184.44%128K120.37%119K125.93%122K17.98%210K-3.39%57K
Change In working capital 227.54%2.22M-142.44%-1.25M62.23%-318K735.36%5.08M258.63%2.31M-77.88%679K735.50%2.94M68.14%-842K-63.81%608K-72.86%643K
-Change in prepaid assets 98.99%396K-77.06%320K69.92%-114K245.28%1.43M337.36%216K-67.22%199K3,132.61%1.4M73.95%-379K5.74%-985K-128.98%-91K
-Change in payables and accrued expense 433.53%1.83M-211.88%-1.56M-134.88%-1.42M198.74%3.09M168.73%1.95M-84.36%343K350.81%1.4M54.48%-605K-43.52%1.03M-62.07%726K
-Change in other current assets --0--0759.15%1.22M-0.18%566K0.00%142K-0.70%141K0.00%141K0.00%142K-35.86%567K0.71%142K
-Change in other current liabilities 50.00%-2K-200.00%-3K---3K42.86%-4K97.76%-3K-103.13%-4K--3K--0-158.33%-7K---134K
Cash from discontinued investing activities
Operating cash flow 32.67%-7.09M-22.99%-9.83M30.78%-7.85M-12.51%-39.89M-26.88%-10.03M-47.20%-10.54M11.56%-7.99M0.20%-11.34M-88.09%-35.46M-9.60%-7.9M
Investing cash flow
Cash flow from continuing investing activities -10.31%8.16M194.05%11.7M293.09%14.19M127.84%15M4,666.50%9.27M117.48%9.1M347.82%3.98M-7.35M-517.86%-53.87M-968.42%-203K
Net PPE purchase and sale --0---------206.67%-138K--05,200.00%51K--------82.14%-45K--0
Net investment purchase and sale -9.80%8.16M180.71%11.7M293.09%14.19M128.12%15.14M4,666.50%9.27M117.38%9.05M366.90%4.17M---7.35M---53.82M---203K
Cash from discontinued investing activities
Investing cash flow -10.31%8.16M194.05%11.7M293.09%14.19M127.84%15M4,666.50%9.27M117.48%9.1M347.82%3.98M---7.35M-517.86%-53.87M-968.42%-203K
Financing cash flow
Cash flow from continuing financing activities -1.92M-78.92%43K-41,337.50%-6.6M-98.06%438K-98.98%218K0750.00%204K100.00%16K-63.89%22.54M10,857.29%21.41M
Net issuance payments of debt ---1.92M---1K---6.68M--0--0--0--0--08,641.03%19.99M----
Net common stock issuance --0--0--80K-87.17%299K-86.74%172K--0--127K--0-96.26%2.33M--1.3M
Proceeds from stock option exercised by employees --0-42.86%44K--0-38.22%139K-62.90%46K--0220.83%77K128.57%16K-33.63%225K254.29%124K
Cash from discontinued financing activities
Financing cash flow ---1.92M-78.92%43K-41,337.50%-6.6M-98.06%438K-98.98%218K--0750.00%204K100.00%16K-63.89%22.54M10,857.29%21.41M
Net cash flow
Beginning cash position -2.18%13.98M-33.36%12.06M-66.51%12.32M-64.49%36.77M-45.23%12.86M-82.48%14.29M-80.37%18.1M-64.49%36.77M119.91%103.55M-78.85%23.47M
Current changes in cash 40.57%-854K150.42%1.92M98.63%-255K63.38%-24.46M-104.05%-539K97.53%-1.44M64.15%-3.81M-64.46%-18.67M-218.27%-66.78M279.04%13.3M
End cash Position 2.11%13.13M-2.18%13.98M-33.36%12.06M-66.51%12.32M-66.51%12.32M-45.23%12.86M-82.48%14.29M-80.37%18.1M-64.49%36.77M-64.49%36.77M
Free cash flow 32.34%-7.09M-20.15%-9.83M30.78%-7.85M-12.75%-40.03M-26.88%-10.03M-46.47%-10.48M9.90%-8.18M0.20%-11.34M-53.67%-35.5M-9.31%-7.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data